
Teneligliptin (20mg) + Metformin (1000mg)
Active composition
+1 more active ingredient
Teneligliptin inhibits DPP-4, increasing incretin levels and enhancing insulin secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Neliptin M 1000 Tablet ER is a combined oral medication containing Metformin 1000mg and Teneligliptin 20mg, designed for extended release. This pharmaceutical formulation is indicated in the management of type 2 diabetes mellitus as an adjunct to diet and exercise. Metformin, a biguanide, decreases hepatic glucose production, while Teneligliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhances the secretion of insulin and decreases the release of glucagon. This dual mechanism of action provides improved glycemic control, reducing the risk of hyperglycemia-related complications in patients with type 2 diabetes mellitus. It is essential to maintain regular monitoring of blood glucose levels and adjust the dosage as necessary under medical supervision.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Neliptin M 1000 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Neliptin M 1000 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Neliptin M 1000 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Neliptin M 1000 Tablet ER may be needed. Please consult your doctor. Use of Neliptin M 1000 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
It is not known whether Neliptin M 1000 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Neliptin M 1000 Tablet ER is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Neliptin M 1000 Tablet ER

Metformin (1000mg) + Teneligliptin (20mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Teneligliptin inhibits DPP-4, increasing incretin levels and enhancing insulin secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Neliptin M 1000 Tablet ER is a combined oral medication containing Metformin 1000mg and Teneligliptin 20mg, designed for extended release. This pharmaceutical formulation is indicated in the management of type 2 diabetes mellitus as an adjunct to diet and exercise. Metformin, a biguanide, decreases hepatic glucose production, while Teneligliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhances the secretion of insulin and decreases the release of glucagon. This dual mechanism of action provides improved glycemic control, reducing the risk of hyperglycemia-related complications in patients with type 2 diabetes mellitus. It is essential to maintain regular monitoring of blood glucose levels and adjust the dosage as necessary under medical supervision.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Neliptin M 1000 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Neliptin M 1000 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Neliptin M 1000 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Neliptin M 1000 Tablet ER may be needed. Please consult your doctor. Use of Neliptin M 1000 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
It is not known whether Neliptin M 1000 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Neliptin M 1000 Tablet ER is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Neliptin M 1000 Tablet ER













